Biomarkers of cardiovascular disease and mortality risk in patients with advanced CKD

Clinical Journal of the American Society of Nephrology

Volumn 11, Issue 7, 2016, Pages 1163-1172

  Sun, Jia ^a   Axelsson, Jonas ^a   Machowska, Anna ^a   Heimbürger, Olof ^a   Bárány, Peter ^a   Lindholm, Bengt ^a   Lindström, Karin ^a   Stenvinkel, Peter ^a   Qureshi, Abdul Rashid ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Biomarkers; C Reactive Protein; Cardiovascular disease; Chronic kidney disease; Follow Up Studies; Humans; Inflammation; Interleukin 6; Mortality; Renal Insufficiency, Chronic

Indexed keywords

ALBUMIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CREATININE; INTERLEUKIN 6; OROSOMUCOID; TRINITROTOLUENE; TUMOR NECROSIS FACTOR; CELL ADHESION MOLECULE; FERRITIN; IGF1 PROTEIN, HUMAN; SERUM ALBUMIN; SOMATOMEDIN C; TROPONIN T; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ANTHROPOMETRY; ARTICLE; BIOCHEMICAL ANALYSIS; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; GLOBAL ASSESSMENT OF FUNCTIONING; GRIP STRENGTH; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MIDDLE AGED; NUTRITIONAL STATUS; RECEIVER OPERATING CHARACTERISTIC; AGE; AGED; BLOOD; CAUSE OF DEATH; COMORBIDITY; DIABETES MELLITUS; METABOLISM; MORTALITY; PREDICTIVE VALUE; PROTEIN CALORIE MALNUTRITION; RISK FACTOR; SMOKING; THROMBOCYTE COUNT;

ADULT; AGE FACTORS; AGED; BIOMARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CELL ADHESION MOLECULES; COMORBIDITY; DIABETES MELLITUS; FEMALE; FERRITINS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-6; KIDNEY FAILURE, CHRONIC; LEUKOCYTE COUNT; MALE; MIDDLE AGED; OROSOMUCOID; PLATELET COUNT; PREDICTIVE VALUE OF TESTS; PROTEIN-ENERGY MALNUTRITION; RISK FACTORS; ROC CURVE; SERUM ALBUMIN; SMOKING; TROPONIN T; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84991240023     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.10441015     Document Type: Article

References (49)

1. Fried LF, Shlipak MG, Crump C, Bleyer AJ, Gottdiener JS, Kronmal RA, Kuller LH, Newman AB: Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals. J Am Coll Cardiol 41: 1364-1372, 2003
2. Kooman JP, Kotanko P, Schols AM, Shiels PG, Stenvinkel P: Chronic kidney disease and premature ageing. Nat Rev Nephrol 10: 732-742, 2014
3. Levin A, Foley RN: Cardiovascular disease in chronic renal insufficiency. Am J Kidney Dis 36[Suppl 3]: S24-S30, 2000
4. Menon V, Gul A, Sarnak MJ: Cardiovascular risk factors in chronic kidney disease. Kidney Int 68: 1413-1418, 2005
5. Ross R: Atherosclerosis-an inflammatory disease. N Engl J Med 340: 115-126, 1999
6. Zoccali C, Mallamaci F, Tripepi G: Inflammatory proteins as predictors of cardiovascular disease in patients with end-stage renal disease. Nephrol Dial Transplant 19[Suppl 5]: V67-V72, 2004
7. Nishimura K, Okamura T, Watanabe M, Nakai M, Takegami M, Higashiyama A, Kokubo Y, Okayama A, Miyamoto Y: Predicting coronary heart disease using risk factor categories for a Japanese urban population, and comparison with the Framingham risk score: The Suita study. J Atheroscler Thromb 21: 784-798, 2014
8. Park SH, Stenvinkel P, Lindholm B: Cardiovascular biomarkers in chronic kidney disease. J Ren Nutr 22: 120-127, 2012
9. Stenvinkel P: Chronic kidney disease: A public health priority and harbinger of premature cardiovascular disease. J Intern Med 268: 456-467, 2010
10. Weiner DE, Tighiouart H, Griffith JL, Elsayed E, Levey AS, Salem DN, Sarnak MJ: Kidney disease, Framingham risk scores, and cardiac and mortality outcomes. Am JMed 120: 552.e1-552.e8, 2007
11. Zoccali C: Traditional and emerging cardiovascular and renal risk factors: An epidemiologic perspective. Kidney Int 70: 26-33, 2006
12. Doi T, Yamamoto S, Morinaga T, Sada KE, Kurita N, Onishi Y: Risk score to predict 1-year mortality after haemodialysis initiation in patients with stage 5 chronic kidney disease under predialysis nephrology care. PLoS One 10: e0129180, 2015
13. Matsushita K, Sang Y, Ballew SH, Shlipak M, Katz R, Rosas SE, Peralta CA, Woodward M, Kramer HJ, Jacobs DR, Sarnak MJ, Coresh J: Subclinical atherosclerosis measures for cardiovascular prediction in CKD. J Am Soc Nephrol 26: 439-447, 2015
14. Axelsson J, Bergsten A, Qureshi AR, Heimbürger O, Bárány P, Lönnqvist F, Lindholm B, Nordfors L, Alvestrand A, Stenvinkel P: Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance. Kidney Int 69: 596-604, 2006
15. Manzano-Fernández S, Januzzi JL, Boronat-García M, Pastor P, Albaladejo-Otón MD, Garrido IP, Bayes-Genis A, Valdés M, Pascual-Figal DA: Impact of kidney dysfunction on plasma and urinaryN-terminal pro-B-type natriuretic peptide in patients with acute heart failure. Congest Heart Fail 16: 214-220, 2010
16. Twerenbold R, Wildi K, Jaeger C, Gimenez MR, Reiter M, Reichlin T, Walukiewicz A, Gugala M, Krivoshei L, Marti N, Moreno Weidmann Z, Hillinger P, Puelacher C, Rentsch K, Honegger U, Schumacher C, Zurbriggen F, Freese M, Stelzig C, Campodarve I, Bassetti S, Osswald S, Mueller C: Optimal cutoff levels of more sensitive cardiac troponin assays for the early diagnosis of myocardial infarction in patients with renal dysfunction. Circulation 131: 2041-2050, 2015
17. Kalantar-Zadeh K, Don BR, Rodriguez RA, Humphreys MH: Serum ferritin is a marker of morbidity and mortality in hemodialysis patients. Am J Kidney Dis 37: 564-572, 2001
18. Honda H, Qureshi AR, Heimbürger O, Barany P, Wang K, Pecoits-Filho R, Stenvinkel P, Lindholm B: Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis 47: 139-148, 2006
19. Kalantar-Zadeh K: Recent advances in understanding the malnutrition-inflammation-cachexia syndrome in chronic kidney disease patients: What is next? Semin Dial 18: 365-369, 2005
20. Stenvinkel P, Heimbürger O, Paultre F, Diczfalusy U, Wang T, Berglund L, Jogestrand T: Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 55: 1899-1911, 1999
21. Zhang L, Kao WH, Berthier-Schaad Y, Plantinga L, Fink N, Smith MW, Coresh J: C-reactive protein haplotype predicts serum C-reactive protein levels but not cardiovascular disease risk in a dialysis cohort. Am J Kidney Dis 49: 118-126, 2007
22. Zoccali C, Tripepi G, Mallamaci F: Dissecting inflammation in ESRD: Do cytokines and C-reactive protein have a complementary prognostic value for mortality in dialysis patients? J Am Soc Nephrol 17[Suppl 3]: S169-S173, 2006
23. Jia T, Gama Axelsson T, Heimbürger O, Bárány P, Lindholm B, Stenvinkel P, Qureshi AR: IGF-1 and survival in ESRD. Clin J Am Soc Nephrol 9: 120-127, 2014
24. Qureshi AR, Alvestrand A, Danielsson A, Divino-Filho JC, Gutierrez A, Lindholm B, Bergström J: Factors predicting malnutrition in hemodialysis patients: A cross-sectional study. Kidney Int 53: 773-782, 1998
25. Pecoits-Filho R, Bárány P, Lindholm B, Heimbürger O, Stenvinkel P: Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant 17: 1684-1688, 2002
26. Suliman ME, Qureshi AR, Heimbürger O, Lindholm B, Stenvinkel P: Soluble adhesion molecules in end-stage renal disease: A predictor of outcome. Nephrol Dial Transplant 21: 1603-1610, 2006
27. Stenvinkel P, Lindholm B, Heimbürger M, Heimbürger O: Elevated serum levels of soluble adhesion molecules predict death in pre-dialysis patients: Association with malnutrition, inflammation, and cardiovascular disease. Nephrol Dial Transplant 15: 1624-1630, 2000
28. Löwbeer C, Stenvinkel P, Pecoits-Filho R, Heimbürger O, Lindholm B, Gustafsson SA, Seeberger A: Elevated cardiac troponin T in predialysis patients is associated with inflammation and predicts mortality. J Intern Med 253: 153-160, 2003
29. Kimmel PL, Phillips TM, Simmens SJ, Peterson RA, Weihs KL, Alleyne S, Cruz I, Yanovski JA, Veis JH: Immunologic function and survival in hemodialysis patients. Kidney Int 54: 236-244, 1998
30. Molnar MZ, Streja E, Kovesdy CP, Budoff MJ, Nissenson AR, Krishnan M, Anker SD, Norris KC, Fonarow GC, Kalantar-Zadeh K: High platelet count as a link between renal cachexia and cardiovascularmortality in end-stage renal disease patients. AmJ Clin Nutr 94: 945-954, 2011
31. Yamamoto T, Qureshi AR, Anderstam B, Heimbürger O, Bárány P, Lindholm B, Stenvinkel P, Axelsson J: Clinical importance of an elevated circulating chemerin level in incident dialysis patients. Nephrol Dial Transplant 25: 4017-4023, 2010
32. Gama-Axelsson T, Heimbürger O, Stenvinkel P, Bárány P, Lindholm B, Qureshi AR: Serum albumin as predictor of nutritional status in patients with ESRD. Clin J Am Soc Nephrol 7: 1446-1453, 2012
33. Yuan J, Guo Q, Qureshi AR, Anderstam B, Eriksson M, Heimbürger O, Bárány P, Stenvinkel P, Lindholm B: Circulating vascular endothelial growth factor (VEGF) and its soluble receptor 1 (sVEGFR-1) are associated with inflammation and mortality in incident dialysis patients. Nephrol Dial Transplant 28: 2356-2363, 2013
34. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419, 1985
35. Grubb A, Horio M, Hansson LO, Björk J, Nyman U, Flodin M, Larsson A, Bökenkamp A, Yasuda Y, Blufpand H, Lindström V, Zegers I, Althaus H, Blirup-Jensen S, Itoh Y, Sjöström P, Nordin G, Christensson A, Klima H, Sunde K, Hjort-Christensen P, Armbruster D, Ferrero C: Generation of a new cystatin C-based estimating equation for glomerular filtration rate by use of 7 assays standardized to the international calibrator. Clin Chem 60: 974-986, 2014
36. Spoto B, Mattace-Raso F, Sijbrands E, Leonardis D, Testa A, Pisano A, Pizzini P, Cutrupi S, Parlongo RM, D’Arrigo G, Tripepi G, Mallamaci F, Zoccali C: Association of IL-6 and a functional polymorphism in the IL-6 gene with cardiovascular events in patients with CKD. Clin J Am Soc Nephrol 10: 232-240, 2015
37. Shanahan CM: Mechanisms of vascular calcification in CKDevidence for premature ageing? Nat Rev Nephrol 9: 661-670, 2013
38. Stenvinkel P, Ketteler M, Johnson RJ, Lindholm B, Pecoits-Filho R, Riella M, Heimbürger O, Cederholm T, Girndt M: IL-10, IL-6, and TNF-alpha: Central factors in the altered cytokine network of uremia-the good, the bad, and the ugly. Kidney Int 67: 1216-1233, 2005
39. Tofik R, Swärd P, Ekelund U, Struglics A, Torffvit O, Rippe B, Bakoush O: Plasma pro-inflammatory cytokines, IgM-uria and cardiovascular events in patients with chest pain: A comparative study. Scand J Clin Lab Invest 75: 638-645, 2015
40. Carlsson AC, Carrero JJ, Stenvinkel P, Bottai M, Barany P, Larsson A, Ärnlöv J: High levels of soluble tumor necrosis factor receptors 1 and 2 and their association with mortality in patients undergoing hemodialysis. Cardiorenal Med 5: 89-95, 2015
41. Meuwese CL, Snaedal S, Halbesma N, Stenvinkel P, Dekker FW, Qureshi AR, Barany P, Heimburger O, Lindholm B, Krediet RT, Boeschoten EW, Carrero JJ: Trimestral variations of C-reactive protein, interleukin-6 and tumour necrosis factor-a are similarly associated with survival in haemodialysis patients. Nephrol Dial Transplant 26: 1313-1318, 2011
42. Kalantar-Zadeh K: Inflammatory markermania in chronic kidney disease: Pentraxins at the crossroad of universal soldiers of inflammation. Clin J Am Soc Nephrol 2: 872-875, 2007
43. Carrero JJ, Park SH, Axelsson J, Lindholm B, Stenvinkel P: Cytokines, atherogenesis, and hypercatabolism in chronic kidney disease: A dreadful triad. Semin Dial 22: 381-386, 2009
44. Pepys MB: C-reactive protein fifty years on. Lancet 1: 653-657, 1981
45. Hickman PE, McGill D, Potter JM, Koerbin G, Apple FS, Talaulikar G: Multiple biomarkers including cardiac troponins T and I measured by high-sensitivity assays, as predictors of longterm mortality in patients with chronic renal failure who underwent dialysis. Am J Cardiol 115: 1601-1606, 2015
46. Walsh M, Wang CY, Ong GS, Tan AS, Mansor M, Shariffuddin II, Hashim NH, Lai HY, Undok AW, Kolandaivel UN, Vajiravelu V, Garg AX, Cuerden M, Guyatt G, Thabane L, Mooney J, Lee V, Chow C, Devereaux PJ: Kidney function alters the relationship between postoperative troponin T level and death. J AmSoc Nephrol 26: 2571-2577, 2015
47. Eckardt KU, Gillespie IA, Kronenberg F, Richards S, Stenvinkel P, Anker SD, Wheeler DC, de Francisco AL, Marcelli D, Froissart M, Floege J; ARO Steering Committee: High cardiovascular event rates occur within the first weeks of starting hemodialysis. Kidney Int 88: 1117-1125, 2015
48. Snaedal S, Heimbürger O, Qureshi AR, Danielsson A, Wikström B, Fellström B, Fehrman-Ekholm I, Carrero JJ, Alvestrand A, Stenvinkel P, Bárány P: Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: Implications for patient survival. Am J Kidney Dis 53: 1024-1033, 2009
49. Meuwese CL, Carrero JJ, Stenvinkel P: Recent insights in inflammation- associated wasting in patients with chronic kidney disease. Contrib Nephrol 171: 120-126, 2011